Recent Updates
Recently added Catalysts
BIIB

Free Genetic Testing Initiative to be Available Nationally at Hemophilia Treatment Centers

Key Takeaway: Free Genetic Testing Initiative to be Available Nationally at Hemophilia Treatment Centers

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+34%
120-day peak, hindsight
Typical move
1.8%
average across 15 past catalysts
Lead asset
Alefacept
Phase 3 · Chronic Plaque Psoriasis

Full Press Release Details

Free Genetic Testing Initiative to be Available Nationally at Hemophilia Treatment Centers.
Last updated: Oct 2, 2013